Latis Srl   Report issue

For profit Phase 2 Phase 3
Founded: Genoa Italy (2002)

Organization Overview

First Clinical Trial
2013
NCT02931357
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Latis | Latis Srl | Latis S.r.l. | Latis Srl, Genova, Italy

Active Ingredients

Drugs in Phase 3 Trials (4)

cetylpyridinium chloride (1 trial)

hyaluronic acid (1 trial)

lidocaine (xylocaine) (1 trial)

tizanidine (zanaflex) (1 trial)

Drugs in Phase 2 Trials (1)

get 73 (2 trials)

Drugs in Other Trials (4)

abo-glyc (1 trial)

aqualief (1 trial)

royal jelly (1 trial)

wild blueberry extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 2)

Alcoholism (Phase 2)

Back Pain (Phase 3)

Low Back Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 9